ATE393165T1 - Reinigungsverfahren für bakterielles cytolysin - Google Patents
Reinigungsverfahren für bakterielles cytolysinInfo
- Publication number
- ATE393165T1 ATE393165T1 AT05797390T AT05797390T ATE393165T1 AT E393165 T1 ATE393165 T1 AT E393165T1 AT 05797390 T AT05797390 T AT 05797390T AT 05797390 T AT05797390 T AT 05797390T AT E393165 T1 ATE393165 T1 AT E393165T1
- Authority
- AT
- Austria
- Prior art keywords
- bacterial cytolysin
- salt
- extract
- cytolysin
- culture
- Prior art date
Links
- 102000004503 Perforin Human genes 0.000 title abstract 5
- 108010056995 Perforin Proteins 0.000 title abstract 5
- 230000001580 bacterial effect Effects 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 4
- 239000003599 detergent Substances 0.000 abstract 2
- 238000004191 hydrophobic interaction chromatography Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0421083.7A GB0421083D0 (en) | 2004-09-22 | 2004-09-22 | Purification process |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE393165T1 true ATE393165T1 (de) | 2008-05-15 |
Family
ID=33397075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05797390T ATE393165T1 (de) | 2004-09-22 | 2005-09-20 | Reinigungsverfahren für bakterielles cytolysin |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070231876A1 (de) |
EP (1) | EP1791860B1 (de) |
JP (1) | JP4934591B2 (de) |
AT (1) | ATE393165T1 (de) |
CA (1) | CA2580113C (de) |
CY (1) | CY1107960T1 (de) |
DE (1) | DE602005006294T2 (de) |
DK (1) | DK1791860T3 (de) |
ES (1) | ES2304724T3 (de) |
GB (1) | GB0421083D0 (de) |
HR (1) | HRP20080242T3 (de) |
PL (1) | PL1791860T3 (de) |
PT (1) | PT1791860E (de) |
SI (1) | SI1791860T1 (de) |
WO (1) | WO2006032499A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0408094A (pt) | 2003-03-13 | 2006-02-14 | Glaxosmithkline Biolog Sa | processo para purificação de uma citolisina bacteriana, citolisina bacteriana, conjugado de polissacarìdeo capsular-pneumolisina bacteriano, composição imunogênica, vacina, processo de produção da vacina, método de tratamento ou prevenção de infecção por streptococcus pneumoniae, e, uso da pneumolisina ou do conjugado de polissacarìdeo-pneumolisina bacteriano |
GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
US20090010959A1 (en) | 2005-12-22 | 2009-01-08 | Ralph Leon Biemans | Pneumococcal Polysaccharide Conjugate Vaccine |
EP2054080A4 (de) * | 2006-08-03 | 2010-11-03 | Newcastle Innovation Ltd | Behandlung und prävention von allergischen atemwegserkrankungen |
BRPI0813307C1 (pt) | 2007-06-26 | 2021-05-25 | Glaxosmithkline Biologicals Sa | composição imunogênica, vacina, e, processo para fabricar a vacina |
WO2009094730A1 (en) * | 2008-02-01 | 2009-08-06 | Newcastle Innovation Limited | Vaccine compositions |
NZ620441A (en) | 2009-09-03 | 2015-08-28 | Pfizer Vaccines Llc | Pcsk9 vaccine |
CN103687600B (zh) * | 2011-03-22 | 2016-05-04 | 印度血清研究所私人有限公司 | 一种制备多糖的方法 |
HRP20240042T1 (hr) * | 2011-04-22 | 2024-03-29 | Wyeth Llc | Pripravci koji se odnose na mutantni toksin iz bakterije clostridium difficile i odgovarajući postupci |
JP2014515035A (ja) | 2011-05-17 | 2014-06-26 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ストレプトコッカス・ニューモニエに対するワクチン |
SG11201604728XA (en) | 2014-01-21 | 2016-08-30 | Pfizer | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
US11160855B2 (en) | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
MX2017009308A (es) | 2015-01-15 | 2017-11-08 | Pfizer | Composiciones inmunogenicas para usar en vacunas neumococicas. |
PE20180657A1 (es) | 2015-07-21 | 2018-04-17 | Pfizer | Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados, kits que las comprenden y sus usos |
WO2017085586A1 (en) | 2015-11-20 | 2017-05-26 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
GB201603029D0 (en) | 2016-02-22 | 2016-04-06 | Glaxosmithkline Biolog Sa | Vaccine |
US11241489B2 (en) | 2016-08-05 | 2022-02-08 | Sanofi Pasteur Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
CA3031797A1 (en) | 2016-08-05 | 2018-02-08 | Sanofi Pasteur, Inc. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
HRP20220573T1 (hr) | 2017-01-20 | 2022-06-10 | Pfizer Inc. | Imunogeni pripravci, namijenjeni upotrebi u pneumokoknim cjepivima |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
MX2020007939A (es) | 2018-02-05 | 2020-09-03 | Sanofi Pasteur Inc | Composicion del conjugado proteina-polisacarido multivalente nuemococica. |
MX2020008198A (es) | 2018-02-05 | 2020-09-22 | Sanofi Pasteur Inc | Composicion del conjugado proteina-polisacarido multivalente neumococica. |
TW202011985A (zh) | 2018-04-18 | 2020-04-01 | 韓商Sk生物科學股份有限公司 | 肺炎鏈球菌的莢膜多醣類以及其免疫原性接合體 |
GB201807303D0 (en) * | 2018-05-03 | 2018-06-20 | London School Of Hygeine & Tropical Medicine | Glyconjugate vaccines |
JP2022513458A (ja) | 2018-12-12 | 2022-02-08 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | O-結合型グリコシル化のための修飾キャリアタンパク質 |
US20220016229A1 (en) | 2018-12-12 | 2022-01-20 | Pfizer Inc. | Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof |
JP7239509B6 (ja) | 2019-02-22 | 2023-03-28 | ファイザー・インク | 細菌多糖類を精製するための方法 |
US20220184199A1 (en) | 2019-04-10 | 2022-06-16 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof |
JP2022542316A (ja) | 2019-07-31 | 2022-09-30 | サノフィ パスツール インコーポレイテッド | 多価肺炎球菌多糖体-タンパク質コンジュゲート組成物およびその使用方法 |
CN115362177A (zh) | 2020-02-21 | 2022-11-18 | 辉瑞公司 | 糖类的纯化 |
WO2022084852A1 (en) | 2020-10-22 | 2022-04-28 | Pfizer Inc. | Methods for purifying bacterial polysaccharides |
CA3200602A1 (en) | 2020-11-04 | 2022-05-12 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
EP4333879A1 (de) | 2021-05-03 | 2024-03-13 | Pfizer Inc. | Impfung gegen bakterielle und betacoronavirus-infektionen |
WO2022234416A1 (en) | 2021-05-03 | 2022-11-10 | Pfizer Inc. | Vaccination against pneumoccocal and covid-19 infections |
CA3221075A1 (en) | 2021-05-28 | 2022-12-01 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
AU2022281543A1 (en) | 2021-05-28 | 2023-11-23 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
WO2023135515A1 (en) | 2022-01-13 | 2023-07-20 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
WO2023161817A1 (en) | 2022-02-25 | 2023-08-31 | Pfizer Inc. | Methods for incorporating azido groups in bacterial capsular polysaccharides |
WO2023218322A1 (en) | 2022-05-11 | 2023-11-16 | Pfizer Inc. | Process for producing of vaccine formulations with preservatives |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2160570T3 (es) * | 1988-12-16 | 2001-11-16 | Nederlanden Staat | Mutantes de neumolisina y vacunas de neumococos fabricadas a partir de los mismos. |
DE4133707A1 (de) * | 1991-10-11 | 1993-04-15 | Behringwerke Ag | Verfahren zur reinigung von streptolysin o, intaktes streptolysin o erhaeltlich nach diesem verfahren und seine verwendung |
US5652125A (en) * | 1996-06-10 | 1997-07-29 | Pharmacia S.P.A. | Process for preparing daunorubicin |
KR100619350B1 (ko) * | 1997-07-21 | 2006-09-05 | 박스터 헬쓰케어 에스.에이. | 변형 면역성 뉴멀리신 백신조성물 |
BRPI0408094A (pt) * | 2003-03-13 | 2006-02-14 | Glaxosmithkline Biolog Sa | processo para purificação de uma citolisina bacteriana, citolisina bacteriana, conjugado de polissacarìdeo capsular-pneumolisina bacteriano, composição imunogênica, vacina, processo de produção da vacina, método de tratamento ou prevenção de infecção por streptococcus pneumoniae, e, uso da pneumolisina ou do conjugado de polissacarìdeo-pneumolisina bacteriano |
JP4578067B2 (ja) * | 2003-06-06 | 2010-11-10 | 宏 清水 | 局所医薬組成物 |
-
2004
- 2004-09-22 GB GBGB0421083.7A patent/GB0421083D0/en not_active Ceased
-
2005
- 2005-09-20 DK DK05797390T patent/DK1791860T3/da active
- 2005-09-20 PL PL05797390T patent/PL1791860T3/pl unknown
- 2005-09-20 US US11/575,676 patent/US20070231876A1/en not_active Abandoned
- 2005-09-20 CA CA2580113A patent/CA2580113C/en not_active Expired - Fee Related
- 2005-09-20 PT PT05797390T patent/PT1791860E/pt unknown
- 2005-09-20 SI SI200530269T patent/SI1791860T1/sl unknown
- 2005-09-20 JP JP2007531717A patent/JP4934591B2/ja not_active Expired - Fee Related
- 2005-09-20 ES ES05797390T patent/ES2304724T3/es active Active
- 2005-09-20 EP EP05797390A patent/EP1791860B1/de active Active
- 2005-09-20 WO PCT/EP2005/010258 patent/WO2006032499A1/en active IP Right Grant
- 2005-09-20 DE DE602005006294T patent/DE602005006294T2/de active Active
- 2005-09-20 AT AT05797390T patent/ATE393165T1/de active
-
2008
- 2008-05-26 CY CY20081100535T patent/CY1107960T1/el unknown
- 2008-06-02 HR HR20080242T patent/HRP20080242T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE602005006294D1 (de) | 2008-06-05 |
HRP20080242T3 (en) | 2008-09-30 |
US20070231876A1 (en) | 2007-10-04 |
GB0421083D0 (en) | 2004-10-27 |
JP4934591B2 (ja) | 2012-05-16 |
SI1791860T1 (sl) | 2008-08-31 |
WO2006032499A1 (en) | 2006-03-30 |
PL1791860T3 (pl) | 2008-09-30 |
CA2580113A1 (en) | 2006-03-30 |
PT1791860E (pt) | 2008-05-20 |
CA2580113C (en) | 2018-01-16 |
ES2304724T3 (es) | 2008-10-16 |
CY1107960T1 (el) | 2013-09-04 |
DE602005006294T2 (de) | 2008-08-14 |
DK1791860T3 (da) | 2008-07-14 |
EP1791860B1 (de) | 2008-04-23 |
JP2008513408A (ja) | 2008-05-01 |
EP1791860A1 (de) | 2007-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE393165T1 (de) | Reinigungsverfahren für bakterielles cytolysin | |
CR8997A (es) | Produccion de polipeptidos | |
CR8998A (es) | PRODUCCION DE TNFR-Ig Y FUSION DE PROTEINA | |
UA92157C2 (ru) | Способ продуцирования гормона роста | |
NZ591292A (en) | Improved cell composition and methods of making the same | |
EP0976829A3 (de) | Protein-deamiderendes Enzym, dafür kodierendes Gen, Verfahren zur Herstellung und Verwendung davon | |
WO2005033318A3 (en) | Methods for enhancing stress tolerance in plants and methods thereof | |
DE602004014158D1 (de) | Verfahren zur herstellung von l-lysin oder l-threonin unter verwendung von escherichia-bakterien mit abgeschwächter malatenzymaktivität | |
DE602005021379D1 (de) | System und verfahren zur produktion von antikörpern in der pflanzenzellkultur | |
WO2008024769A3 (en) | Intensified perfusion production method | |
NZ593239A (en) | Fusion Collagenase in which affinity TAG is linked and method for producing the same | |
WO2004090096A3 (en) | Methods for neural differentiation of embryonic stem cells using protease passaging techniques | |
ATE324030T1 (de) | Brassica-transformation durch teilchenbeschuss | |
DE60307615D1 (de) | Zellkulturmedium | |
EP1687413B8 (de) | Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle enthaltende pharmazeutische zusammensetzung gegen eine neurodegenerative krankheit | |
ATE415470T1 (de) | Herstellungsverfahren für iturin a und dessen homologe | |
WO2008055671A3 (de) | Verfahren zur aufreinigung wenigstens einer nachzuweisenden zielsubstanz | |
Maruoka et al. | Improvement of desalted paddy soil by the application of fertilizer made of steelmaking slag (Recovery of a Paddy field damaged by the tsunami using fertilizer made of steelmaking slag-1) | |
TW200506057A (en) | Transient production of pharmaceutically important proteins in plants | |
HRP20060190A2 (en) | Biological fertilizer | |
CA2758228C (en) | Method for reducing methoxypyrazines in grapes and grape products | |
WO2008143255A1 (ja) | 細胞集団の製造方法 | |
HUP9903899A2 (hu) | Eljárás L-aminosavak fermentációs előállítására | |
FR2778669B1 (fr) | Procede d'expression d'un complexe forme d'au moins un produit du complexe majeur d'histocompatibilite et d'un peptide chez un phage, phages et complexes ainsi obtenus et leurs applications | |
Kordyum et al. | Simulated microgravity impacts the lipid rafts in plant cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1791860 Country of ref document: EP |